You're contacting media contact of this press release

Title: Online Therapist AI Selects CoreAge Rx as the No.1 Recommended GLP-1 Provider in Latest 2026 Review

United States, 19th Mar 2026 - An independent review published by Online Therapist AI has named CoreAge Rx the #1 recommended GLP-1 provider in its latest March 2026 evaluation of telehealth platforms offering compounded semaglutide and tirzepatide. The review awarded CoreAge Rx an overall rating of 4.9 out of 5.0, citing its combination of affordability, physician oversight, and a transparent pricing model as key factors behind the top ranking.The full review article evaluates GLP-1 telehealth providers across multiple criteria, including medication quality, clinical supervision, pricing transparency, convenience, and patient accessibility. After assessing numerous providers across the industry, Online Therapist AI concluded that CoreAge Rx consistently delivered strong performance in each category, earning the platform its highest recommendation.A Telehealth Model Designed for AccessibilityCoreAge Rx is a telehealth pharmacy based in Wichita Falls, Texas, specializing in personalized prescription medication services delivered through a fully online platform. The company focuses on compounded GLP-1 medications, specifically compounded semaglutide and compounded tirzepatide, which are prescribed under physician supervision and shipped directly to patients.Unlike traditional healthcare settings that may require in-person visits, CoreAge Rx operates through a streamlined digital process. Patients complete an online health assessment, receive an evaluation from a U.S.-based board-certified physician, and if approved, have their prescribed medication shipped directly to their home with complimentary two-day delivery.The platform does not require insurance, membership fees, or ongoing subscription costs, allowing patients to access treatment through a simplified telehealth e...

This press release is issued by King Newswire